British AI company BenevolentAI raises $115 mln at $2 bln valuation


London-based BenevolentAI, which applies artificial intelligence to develop new medicines to treat diseases, announced it has raised $115 million in new funding at a pre-money valuation of $2 billion. Not all investors were disclosed, but the company said backers in the latest round include existing investor Woodford Investment Management, as well as new investors from the United States. The company has now raised more than $200 million since it was founded in 2013.

Source: Press release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!